Evidence map›Paper›PMID 24121138›Full record

ArticleRespiratory physiology & neurobiology2014

Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.

Michael W Calik, Miodrag Radulovacki, David W Carley

Abstract read
In one paragraph

Article in Respiratory physiology & neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Using Cannabis and CBD to Sleep: An Updated Review.Current psychiatry reports · 2024
    Review
  2. Article
  3. Article
  4. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  5. Cannabinoids, Endocannabinoids and Sleep.Frontiers in molecular neuroscience · 2020
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Treatments for Obstructive Sleep Apnea.Journal of clinical outcomes management : JCOM · 2016
    Article
  11. A method of nodose ganglia injection in Sprague-Dawley rat.Journal of visualized experiments : JoVE · 2014
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael W CalikCenter for Narcolepsy, Sleep and Health Research, University of Illinois at Chicago, Chicago, IL, USA; Department of Biobehavioral Health Science, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: mcalik@uic.edu.
Miodrag Radulovacki
David W Carley
University of Illinois Chicago · US

Funding

Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept TrialUM1HL112856 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CARLEY, DAVID W., RADULOVACKI, MIODRAG G · 2012 to 2014
$4.9M
NHLBI NIH HHS 1UM1HL112856NHLBI NIH HHS UM1 HL112856
6 · The paper itself

Abstract

Obstructive sleep apnea represents a significant public health concern. Afferent vagal activation is implicated in increased apnea susceptibility by reducing upper airway muscle tone via activation of serotonin receptors in the nodose ganglia. Previous investigations demonstrated that systemically administered cannabinoids can be used therapeutically to decrease the apnea/hypopnea index in rats and in humans. However, cannabinoids have effects on both the central and peripheral nervous systems, and the exact mechanism of decreased apnea/hypopnea index with cannabinoids is unknown. Here, we hypothesized that intranodose ganglion injections of a cannabinoid will attenuate 5-HT-induced reflex apnea and increase upper airway muscle tone. We show that dronabinol injected locally into the nodose ganglia suppresses 5-HT-induced reflex apnea, and increases phasic, but not tonic, activation of the genioglossus. These data support the view that dronabinol stabilizes respiratory pattern and augments upper airway muscles by acting at the nodose ganglia. These findings underscore a therapeutic potential of dronabinol for the treatment of obstructive sleep apnea.

Indexed as

Analgesics, Non-NarcoticAnimalsApneaDisease Models, AnimalDose-Response Relationship, DrugDronabinolElectromyographyMaleMuscle, SkeletalNodose GanglionRatsRats, Sprague-DawleyRespirationSerotoninAnalgesics, Non-NarcoticDronabinolSerotoninCannabinoidsDronabinolGenioglossusNodose gangliaOSASerotonin

Identifiers

PMID24121138
PMCPMC3880550
OpenAlexW2021250509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.